Effects of Insomnia Treatment on Metabolism in Patients with Depression
Brief description of study
Are you currently depressed and have trouble sleeping? Are you between the ages of 21 and 60? You may be eligible for one of our current research studies:
Cognitive behavioral therapy for insomnia (CBT-I) has been the ‘gold standard’ for the treatment of insomnia. Insomnia and depression are highly related, and there’s a need for developing new treatments for depression. Previous research has indicated that, when a patient has both conditions, treating the insomnia may reduce the severity of depressive symptoms or cause the depression to go into remission. Other research has shown changes in metabolism when a patient’s insomnia is treated. One purpose of this study is to understand the relationships among insomnia, metabolism, and depression.
Cognitive behavioral therapy for insomnia (CBT-I) has been the ‘gold standard’ for the treatment of insomnia. Insomnia and depression are highly related, and there’s a need for developing new treatments for depression. Previous research has indicated that, when a patient has both conditions, treating the insomnia may reduce the severity of depressive symptoms or cause the depression to go into remission. Other research has shown changes in metabolism when a patient’s insomnia is treated. One purpose of this study is to understand the relationships among insomnia, metabolism, and depression.
Detailed description of study
Your participation will last approximately 5 months. The first visit is a screening visit
where you will be asked to answer questions about your sleep, thoughts,
and feelings as well as a provide a fasting blood draw. If eligible, you
will be provided two devices. One is a portable sleep monitoring device
that you will wear for one night and a wrist worn device for one week.
After study staff receive the devices back you will be scheduled for CBT-I.
CBT-I is currently being offered in-person or via telemedicine, at the patients' preference.
CBT-I is currently being offered in-person or via telemedicine, at the patients' preference.
Following treatment, you will be given the wrist worn device to wear for
a week and will come in to the office for another fasting blood draw
and to answer questionnaires about 2 weeks after treatment. Three months
after the end of treatment, you will be asked to complete a series of
questionnaires online.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Depression,Insomnia
-
Age: Between 21 Years - 60 Years
-
Gender: All
Updated on
13 Aug 2021.
Study ID: 831841